2 YEARS EXPERIENCE WITH THE CAVERNOSAL AUTOINJECTION THERAPY FOR ERECTILE DYSFUNCTION

  • 1 September 1987
    • journal article
    • research article
    • Vol. 26  (5) , 294-296
Abstract
Between February 1984 and January 1987, 186 patients with erectile dysfunction were selected for cavernosal autoinjection therapy (CAT). After more than 4800 protocolled autoinjections and 10-230 CAT/pt., no cavernous fibrosis, penile deviation or cavernitis occurred. The only serious side effects were prolonged erections in about 10% during diagnostic and less than 1.permill. during therapeutic use. These prolonged erections could be easily treated by puncture and aspiration of corpora cavernosa or intravernosa or intracavernosal injection of Metaraminol.

This publication has 0 references indexed in Scilit: